- Requirements and specific rules for adaptation of:
- in vitro and in vivo mutagenicity studies, specifying when further studies are needed based on mutagenicity concerns;
- reproductive toxicity studies, specifying the preferred animal species and administration routes, and clarifying the conditions triggering the need for further studies based on concerns;
- aquatic toxicity studies, clarifying when long-term studies must be performed instead of short-term studies or in addition to them;
- toxicity studies on terrestrial and sediment organisms, specifying when long-term studies are needed instead of short-term studies and clarifying that long-term testing must investigate both degradation and transformation products; and
- degradation and bioaccumulation studies, specifying when further testing is needed, including investigation of both degradation and transformation products.
- The obligation for only representatives to provide details on the non-EU manufacturer they represent.
- Substance identification information including:
- the requirement to describe the compositions, nanoform or set of similar nanoforms related to information submitted to fulfil information requirements under Annex VII-X of EU REACH;
- new requirements for reporting a crystal structure and for reporting compositions for substances with unknown or variable composition, complex reaction products or of biological materials (UVCBs); and
- clarified requirements for reporting constituents, impurities, and additives as well as for analytical information.
Apr. 20th, 2022
EU REACH: Upcoming Changes to Information Requirements
Related News
- EU REACH: IUCLID Updated with New REACH Information Requirements
- New Requirements for Nanomaterials under EU REACH
- New Requirements for Nanomaterials under EU REACH
- EU REACH: Tonnage Band Changes Will Be Considered by ECHA in Dossier Evaluation Process
- October 2024: Essential EU & Americas Chemical Regulation Changes